Uncategorized
VIDEO: Gene therapy for wet AMD shows positive results in phase 1/2a study
In this video from the virtual American Society of Retina Specialists meeting, Arshad Khanani, MD, discusses results of a phase 1/2a study of RGX-314 gene therapy (Regenxbio) for the treatment of wet age-related macular degeneration.